Drug-resistant epilepsy.

By Patrick Kwan, S. Schachter, M. Brodie. New England Journal of Medicine, 2011

1,110 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/7bc74f7c62e030e7d63abb7b03438a1887aaf3ae

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. A. Vezzani
2. Heidrun Potschka
3. Wolfgang Löscher

In Pediatrics, Perinatology and Child Health

1. Wolfgang Löscher
2. Heidrun Potschka
3. Patrick Kwan
4. D. Liew
5. Zhibin Chen
6. A. Vezzani
7. M. Brodie

In Psychiatry and Mental health

1. Heidrun Potschka
2. Wolfgang Löscher
3. Patrick Kwan
4. D. Liew
5. Zhibin Chen
6. A. Vezzani
7. M. Brodie

Citations in the corpus

• Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study (2017, background): “(Additional therapeutic options include resective surgery, brain stimulation, and dietary therapy.(2)) To formulate a rational management plan for these patients, it is crucial to understand the long-term clinical courses and patterns of responses to AEDs.”
• Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options (2020, background): “The mechanisms of drug resistance are likely to be variable and multifactorial according to the underlying cause of DRE and, in theory, to the drug’s site of action (Kwan et al., 2011).”